Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3188 results about "Heterologous" patented technology

In cell biology and protein biochemistry, heterologous expression means that a protein is experimentally put into a cell that does not normally make (i.e., express) that protein. Heterologous (meaning 'derived from a different organism') refers to the fact that often the transferred protein was initially cloned from or derived from a different cell type or a different species from the recipient. Typically the protein itself is not transferred, but instead the 'correctly edited' genetic material coding for the protein (the complementary DNA or cDNA) is added to the recipient cell. The genetic material that is transferred typically must be within a format that encourages the recipient cell to express the cDNA as a protein (i.e., it is put in an expression vector). Methods for transferring foreign genetic material into a recipient cell include transfection and transduction. The choice of recipient cell type is often based on an experimental need to examine the protein's function in detail, and the most prevalent recipients, known as heterologous expression systems, are chosen usually because they are easy to transfer DNA into or because they allow for a simpler assessment of the protein's function.

Novel santalene synthase gene as well as encoding protein and application thereof

The invention discloses a novel santalene synthase gene as well as an encoding protein and application thereof. The amino acid sequence of the santalene synthetase is as shown in SEQ ID NO. 2. The invention relates to a method for carrying out functional verification on a new sandalene synthase gene encoding enzyme from sandalwood and carrying out synthesis of sandalene and bergamoene in escherichia coli and tobacco leaves. According to the invention, the enzyme can be massively prepared by utilizing escherichia coli, is applied to synthesis of santalene and bergamoene, can be further applied to synthesis of bergamoene or santalene, and has important significance; the heterologous synthesis of the high-value santalene and the bergamoene in plants can also be realized, and the method has a wide industrial practical prospect and a large-scale development potential.
Owner:SOUTH CHINA BOTANICAL GARDEN CHINESE ACADEMY OF SCI

Schizochytrium limacinum engineering strain for producing EPA (Eicosapentaenoic Acid) by prolonging desaturation path, construction method and application

The invention belongs to the technical field of biochemical engineering and the technical field of bioengineering, and discloses a schizochytrium limacinum engineering strain for producing EPA (eicosapentaenoic acid) by prolonging a desaturation path. Part or all of the extended desaturase genes from thraustochytrium sp. And fusarium sp. And saprolegnia are expressed. According to the invention, extended desaturase genes from various sources are integrated into a schizochytrium limacinum genome, so that a schizochytrium limacinum gene engineering strain efficiently expresses the extended desaturase genes, and a heterologous EPA synthesis path with high synthesis efficiency, short culture period, simple purification method and low cost is provided; a basis is provided for producing grease rich in EPA from schizochytrium limacinum, and the problems of non-sustainability, high cost and the like caused by obtaining EPA from fishes are solved.
Owner:ZHIHE BIOTECHNOLOGY (CHANGZHOU) CO LTD

Streptomyces recombinant engineering strain for producing mycosporine-like metabolite as well as construction method and application of streptomyces recombinant engineering strain

The invention discloses a streptomycete recombinant engineering strain for producing mycosporine-like metabolites, a gene expression cassette is integrated in a genome of the streptomycete recombinant engineering strain, the gene expression cassette is recombined to an attB site of a chromosome in a streptomycete chassis strain, the gene expression cassette is an operon controlled by a single promoter, and the operon is an operon controlled by a single promoter. The operon comprises 2-4 biosynthetic gene elements in MysA, MysB, MysC and MysD or mysDp334 in a synthetic pathway of mycosporine-like metabolites. The invention also discloses a construction method of the streptomyces recombinant engineering strain and an application of the streptomyces recombinant engineering strain in preparation of the mycosporine-like metabolites. A mycosporine-like metabolite is efficiently produced by heterologous expression of a mycosporine-like metabolite synthesis gene element in streptomyces, and four mycosporine-like metabolite products with high yield and strong ultraviolet absorption activity can be obtained by reconstruction of the biosynthesis gene element and recombinant expression in streptomyces pluvialis.
Owner:HAINAN RES INST OF ZHEJIANG UNIV

Saccharomyces cerevisiae strain for efficiently synthesizing cordycepin as well as construction method and application thereof

The invention relates to a saccharomyces cerevisiae strain for efficiently synthesizing cordycepin as well as a construction method and application of the saccharomyces cerevisiae strain, and belongs to the technical field of microbial genetic engineering. The construction method provided by the invention comprises the following steps: carrying out multi-copy genome integrated expression on heterologous codon optimized 2 '-carbonyl-3'-deoxyadenosine reductase genes and 3 '-adenosine monophosphate phosphohydrolase genes, so as to increase the dosage of key enzymes; and supplementing the defective gene of the engineering strain to obtain the saccharomyces cerevisiae strain B5U3 with high yield of cordycepin. According to the obtained saccharomyces cerevisiae strain for efficiently synthesizing the cordycepin, the cordycepin yield reaches 2.92 g / L after shake flask fermentation, the cordycepin yield reaches 7.5 g / L after fermentation in a fermentation tank, and a foundation is laid for safer and more reliable industrial production of the cordycepin.
Owner:NANJING TECH UNIV

C2 carbon source-responsive promoters

The present disclosure concerns promoters engineered to increase their responsiveness to a C2 carbon source. The engineered promoters include at least one external carbon source-responsive element (CSRE) located upstream and proximal to the transcription start site of a gene operatively associated thereto. The engineered promoters can be used in a heterologous nucleic acid molecule, a vector, or an expression cassette to promote the expression of a gene in a microbe. The present disclosure also concerns a method for generating the engineered promoters as well as a method for expressing a gene in a recombination microbial host cell using the engineered promoter(s).
Owner:DANSTAR FERMENT AG

Brazilian sweet protein mutant and application thereof

The invention belongs to the technical field of protein engineering, and discloses a Brazilian sweet protein mutant and application thereof. According to the invention, lysine is used for replacing aspartic acid at the 29th site of Brazilian sweet protein, and / or arginine is used for replacing glutamic acid at the 36th site, and / or alanine is used for replacing aspartic acid at the 50th site, amino acid mutation at the sites is carried out to construct a Brazilian sweet protein mutant, and the Brazilian sweet protein mutant is subjected to heterologous expression in pichia pastoris GS115, so that the Brazilian sweet protein mutant is obtained. And carrying out sweetness performance evaluation on the expressed Brazilian sweet protein mutant. The sweetness property of the double mutant Asp29Lys-Asp50Ala protein is improved by 240% compared with the sweetness property of the Brazilian sweet protein before mutation.
Owner:NANJING TECH UNIV

Chinese cabbage clubroot susceptibility related gene BrSWEET14a as well as construction method and application thereof

The invention provides a Chinese cabbage clubroot susceptibility related gene BrSWEET14a, a construction method and application, belongs to the technical field of plant genetic engineering, and particularly relates to a Chinese cabbage clubroot susceptibility related gene BrSWEET14a. The CDS sequence of the Chinese cabbage BrSWEET14a is as shown in SEQ ID No. 1 (sequence identifier number 1). The gene is transformed into Col-type arabidopsis thaliana through an agrobacterium flower immersion transformation method, a BrSWEET14a heterologous expression arabidopsis thaliana strain is obtained, and the result shows that T-DNA insertion mutant of the BrSWEET14a homologous gene Atsweet14 is more resistant to clubroot than that of the Col-type arabidopsis thaliana, and heterologous expression of Chinese cabbage BrSWEET14a leads to reduction of disease resistance of arabidopsis thaliana to plasmodiophora brassicae. Therefore, the Chinese cabbage BrSWEET14a is closely related to the clubroot disease, and the gene and the homologous gene of the gene in other cruciferous plants can be applied to breeding of the cruciferous plants and other horticultural plants and have a good application prospect.
Owner:ZHEJIANG UNIV +1

Ustilaginoidea virens gene UvASE2 for regulating and controlling rice resistance and application thereof

The invention provides a Ustilaginoidea virens gene UvASE2 for regulating and controlling rice resistance and application of the Ustilaginoidea virens gene UvASE2, and relates to the technical field of plant genetic engineering. The nucleotide sequence of the Ustilaginoidea virens gene UvASE2 is as shown in SEQ ID NO: 1, and the amino acid sequence of the encoding protein of the Ustilaginoidea virens gene UvASE2 is as shown in SEQ ID NO: 2. By constructing a transgenic rice plant for heterologous expression of UvASE2, it is found that the transgenic rice can significantly improve the resistance to false smut and bacterial blight and significantly induce the outbreak of active oxygen. The heterologous expression UvASE2 gene of Ustilaginoidea virens has the function of positively regulating and controlling the disease resistance of rice, and the UvASE2 gene can be used for improving the disease resistance of rice and has important significance on creation of disease-resistant germplasm of rice.
Owner:JILIN AGRICULTURAL UNIV

Increased production of acetyl-coenzyme a and derived products in yeasts

The present disclosure provides a recombinant yeast host cell having a plurality of native and / or heterologous enzymes that function in an engineered metabolic pathway to convert fructose-6-phosphate to acetyl-coenzyme A. The recombinant yeast host cell can be used, for example, in a process for making acetyl-coenzyme A, acetone and / or isopropanol. The plurality of native and / or heterologous enzymes is activated, upregulated, or overexpressed. The plurality of native and / or heterologous enzymes comprises a phosphoketolase; and optionally an acetate kinase; and / or a phosphotransacetylase. The recombinant yeast host cell comprises at least one of: at least two copies of a heterologous nucleic acid molecule encoding the phosphoketolase; a native and / or heterologous enzyme that functions in an engineered non-oxidative pentose phosphate pathway, wherein the native and / or heterologous enzyme is activated, upregulated, or overexpressed; and / or a native and / or heterologous protein that functions in an engineered metabolic pathway to convert pantothenate into acetyl-coenzyme A, wherein the native and / or heterologous protein is activated, upregulated or overexpressed and comprises at least one of: FEN2 or CAB1.
Owner:DANSTAR FERMENT AG +1

Schizochytrium limacinum genetic engineering strain for efficiently producing EPA (Eicosapentaenoic Acid), method and application

The invention belongs to the technical field of gene engineering, and discloses a schizochytrium limacinum gene engineering strain capable of efficiently producing EPA (Eicosapentaenoic Acid). The gene engineering strain is obtained by replacing key catalytic structural domains orfA, orfB-KSB / CLF in a schizochytrium limacinum PKS pathway with corresponding functional domains in a heterologous EPA type PKS pathway. The gene engineering strain can improve the proportion of polyunsaturated fatty acid in the gene engineering strain, especially eicosapentaenoic acid. EPA generated after fermentation of the obtained schizochytrium limacinum genetic engineering strain orfA:: PfaA and KSB / CLF:: PfaC reaches 4.24% and 10.19% of the total grease content respectively, the EPA content is increased by 2.52 and 7.47 times respectively, and compared with an existing schizochytrium limacinum wild type strain, the EPA yield is greatly increased, which shows that the method provided by the invention has extremely high application potential.
Owner:ZHIHE BIOTECHNOLOGY (CHANGZHOU) CO LTD

Lymphocyte targeted lentiviral vectors

Provided herein are lentiviral vectors comprising a mutated, heterologous envelope protein, a targeting protein, and at least one transgene for delivery to and expression by a cell characterized by the targeting protein. Also provided are methods and materials for producing the lentiviral vectors described herein, methods for transducing target cells, and cells transduced by lentiviral vectors according to the present disclosure.
Owner:KELONIA THERAPEUTICS INC

New application of deoxyartemisinin B synthase and isoenzyme A0A2U1PPI9 thereof

The invention discloses a deoxyartemisinin B synthase and an application of an isoenzyme A0A2U1PPI9 of the deoxyartemisinin B synthase in catalysis of dihydroartemisinin acid for biosynthesis of dihydrodeoxyartemisinin B. The invention further discloses a preparation method of the deoxyartemisinin B synthase. The invention discloses a process for biosynthesizing dihydrodeoxidized artemisinin B from dihydroartemisinin for the first time in a biosynthesis pathway of artemisinin, and bioinformatics analysis and in-vitro activity verification of candidate enzymes show that both the deoxidized artemisinin B synthase and the isoenzyme A0A2U1PPI9 have a new function of catalyzing the biosynthesis of dihydrodeoxidized artemisinin B from dihydroartemisinin, so that the application of the deoxidized artemisinin B synthase and the isoenzyme A0A2U1PPI9 to the biosynthesis of dihydrodeoxidized artemisinin B is developed. Lines of artemisinin biosynthetic pathways are enriched, and a theoretical basis is provided for analysis of terminal biosynthetic pathways of artemisinin and heterologous synthesis of artemisinin compounds.
Owner:JINAN UNIVERSITY

Chinese orchid flowering regulation gene CsFTL3 as well as encoding protein and application thereof

The invention discloses a Chinese orchid flowering regulation gene CsFTL3 as well as an encoding protein and application thereof, and belongs to the field of plant molecular biology. The gene CsFTL3 for regulating and controlling flowering of Chinese cymbidium is separated from flower bud cDNA (complementary deoxyribonucleic acid) of a Chinese cymbidium variety 'Xiaoxiang', and 174 amino acids are encoded by the gene CsFTL3. Through construction of an expression vector of the CsFTL3 gene, overexpression in wild-type arabidopsis thaliana and heterologous overexpression of the CsFTL3 gene in the arabidopsis thaliana, it is found that bolting and flowering periods of the arabidopsis thaliana are significantly delayed, flower stems are significantly thickened and increased, the number of rosette leaves is significantly increased, and the growth period is prolonged, which indicates that the gene has the function of delaying the flowering time of the arabidopsis thaliana. The Chinese orchid flowering regulation and control gene can be used for molecular mechanism research of orchid flowering time, delay Chinese orchid flowering time, promote plant vegetative growth, prolong whole Chinese orchid viewing time and promote Chinese orchid genetic improvement and variety breeding.
Owner:ENVIRONMENTAL HORTICULTURE RES INST OF GUANGDONG ACADEMY OF AGRI SCI

Anti-IL-6 humanized nano antibody, recombinant humanized nano antibody and application

The invention belongs to the technical field of immunology, and particularly relates to an anti-IL-6 humanized nano antibody, a recombinant humanized nano antibody and application. The inventor-derived nano antibody 2H3 comprises complementary determining regions CDR1-CDR3, the amino acid sequence of the CDR1 is as shown in SEQ ID NO.13, the amino acid sequence of the CDR2 is as shown in SEQ ID NO.14, and the amino acid sequence of the CDR3 is as shown in SEQ ID NO.15. The inventor-derived nano antibody 2H3 has the advantages that the complementary determining regions CDR1-CDR3 can be used for preparing the antibody; the humanized nano antibody can block the combination of IL-6 and a receptor thereof while keeping the affinity with IL-6, and has a wide application prospect in the preparation of medicines for preventing and / or treating tumors. The humanized nano antibody is low in molecular weight, reduces the immune risk caused by heterology, is more beneficial to penetrating a blood brain barrier, and is easier to reach the interior of a tumor to play a therapeutic effect.
Owner:DONGGUAN SOUTHEAST CENTRAL HOSPITAL (DONGGUAN SOUTHEAST TRADITIONAL CHINESE MEDICINE MEDICAL SERVICE CENTER DONGGUAN FIRST HOSPITAL AFFILIATED TO GUANGDONG MEDICAL UNIVERSITY)

Bicistronic LAMP constructs comprising immune response enhancing genes and methods of use thereof

The present disclosure provides a nucleic acid molecule (e.g., a plasmid or vector) comprising: a nucleic acid sequence encoding a bicistronic or polycistronic LAMP construct comprising a specific fragment of an LAMP endodomain and an antigen domain heterologous to the LAMP protein to provide at least one antigen for eliciting an immune response, wherein the antigen expressed by the construct is optionally processed and presented to a class II MHC molecule; and a nucleic acid sequence encoding an immune response enhancing polypeptide, optionally secreted from a host cell. The nucleic acid molecules can be used, for example, for the treatment of diseases, in particular allergy, infectious diseases, diabetes, hyperproliferative disorders and / or cancer.
Owner:IMMUNOMIC THERAPEUTICS INC

Schizochytrium limacinum genetic engineering strain for remodeling FAS pathway, construction method and application

The invention discloses a schizochytrium limacinum genetic engineering strain capable of remodeling an FAS (Fibroblast Activated Sequence) pathway as well as a construction method and application thereof. The schizochytrium limacinum gene engineering strain is obtained by heterologous expression of a C16 elongase gene E16, a C18 elongase gene E18, a delta 9 desaturase gene D9, a delta 5 desaturase gene D5, a delta 6 desaturase gene D6 and a delta 15 desaturase gene D15 in a schizochytrium limacinum wild type. The recombinant schizochytrium limacinum described herein is capable of producing EPA comprising 2.08% by total fatty acids while also producing DHA comprising at least more than 41% by total fatty acids. In addition, the invention discloses a method for producing unsaturated fatty acid through a double-path channel of PKS and FAS, which is beneficial to promotion and application of a technology for producing EPA and DHA by schizochytrium limacinum.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Recombinant neurospora crassicola strain for producing astaxanthin as well as construction method and application of recombinant neurospora crassicola strain

The invention discloses a recombinant neurospora crassicola strain for producing astaxanthin as well as a construction method and application of the recombinant neurospora crassicola strain. The recombinant neurospora crassa contains key enzymes beta-carotene ketolase and beta-carotene hydroxylase in a heterologous astaxanthin synthetic pathway, and through pathway expression of a targeted subcellular compartment, crosstalk among metabolites is effectively prevented, metabolic flux of a biosynthetic pathway is coordinated, and the activity of the neurospora crassa is improved. The effective contact between the heterologous protein and the substrate in the astaxanthin synthetic route is promoted, the sporulation capability of the heterologous protein is improved, the astaxanthin production and storage capability of the neurospora crassiforme is effectively improved, and the method has relatively high popularization and application values.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1

SCRE10 gene for improving disease resistance of rice and application of SCRE10 gene

The invention belongs to the technical field of plant genetic engineering, and particularly relates to an SCRE10 gene for improving rice disease resistance and application of the SCRE10 gene, the base sequence of the SCRE10 gene is shown as SEQ ID NO.1, and the amino acid sequence of the SCRE10 gene is shown as SEQ ID NO.2. Through construction of a dexamethasone induced expression SCRE10 transgenic rice plant, it is found that the transgenic rice can significantly induce PR gene expression and active oxygen outbreak, and the resistance of rice to false smut and bacterial leaf blight can be improved. The invention proves that heterologous inducible expression of the Ustilaginoidea virens SCRE10 gene has the function of positively regulating the disease resistance of the rice, and the SCRE10 gene can be used for improving the disease resistance of the rice, which is of great significance to the creation of disease-resistant germplasm of the rice.
Owner:JILIN AGRICULTURAL UNIV

Grass carp-derived U6 promoter and application thereof

The invention provides a grass carp sourced U6 promoter. The sequence of the grass carp sourced U6 promoter is shown as one of SEQ ID NO: 1-3. Three grass carp-derived U6 promoters are cloned, the transcriptional activity and cross-species adaptability of the three promoters are analyzed, results show that the three promoters can show transcriptional activity in fish cells and human cells, the transcriptional activity of ciU6-1 is remarkably higher than that of the other two promoters, heterologous DNA can be transcribed in various cells, and the expression of the ciU6-1 in the fish cells and the human cells is improved. And the method can be used for gene editing means based on Cas9.
Owner:INST OF AQUATIC LIFE ACAD SINICA

5-hydroxytryptamine escherichia coli production strain as well as construction method and application thereof

The invention provides a 5-hydroxytryptamine Escherichia coli production strain and a construction method and application thereof, the strain is deleted with tnaA, pykA, trpR, ldhA and trpL genes, trpEfbr, aroGfbr, serAfbr, tktA and prsA genes are up-regulated, gdh and glnAfbr genes are heterologously expressed, a pykF gene is dynamically regulated and controlled, and meanwhile, the production strain carries a plasmid pACYC-FYSPD and a plasmid pETDuet-TM2-RBS-AnTDC; the constructed strain has the characteristic of metabolic balance, the expression levels of a tryptophan hydroxylation-decarboxylation system and a coenzyme tetrahydrobiopterin synthesis regeneration system are adjusted by optimizing the expression intensity of key genes of each precursor and simultaneously by virtue of a double-plasmid system, and 5-hydroxytryptamine can be efficiently synthesized in a culture medium without byproducts.
Owner:TIANJIN UNIV OF SCI & TECH +1

An antimicrobial peptide and its preparation method and use

The present invention belongs to the field of biotechnology, and discloses an antimicrobial peptide and a preparation method and use thereof. The antimicrobial peptide of the present invention is a mixture of any one or more of the polypeptides of RcASScGAK, RcASScGAKS, TGMRcASScGAK, and TGMRcASScGAKS. The present invention also provides a method for preparing the antimicrobial peptide by heterologous co-expression of a whole enzyme and a substrate, as well as a purification process of the antimicrobial peptide, which can successfully obtain high-yield and high-purity antimicrobial peptides, the required reagents are low-priced, the operation steps are simple and easy, and it is suitable for large-scale cultivation and purification; the antimicrobial peptide prepared by the present invention has excellent antimicrobial activity, and provides a new choice for the development of antimicrobial and anti-infective drugs.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Light-driven synthetic flora and application thereof

The invention discloses a light-driven synthetic flora and application thereof. The light-driven synthetic flora comprises phototrophic bacteria and heterotrophic bacteria, the phototrophic bacteria are genetically modified synechococcus slender, and the gene modification comprises construction and expression of heterologous sucrose permease, glyceraldehyde dehydrogenase and sucrose synthase in the synechococcus slender; and the heterotrophic bacteria are the P.adami. According to the light-driven synthetic flora disclosed by the invention, carbon dioxide is converted into cane sugar through photosynthesis of phototrophic bacteria, and the cane sugar is secreted out of cells to provide a carbon source for heterotrophic bacteria; carrying out cell growth and polyhydroxyalkanoate synthesis on the heterotrophic bacteria by using cane sugar; therefore, the light-driven synthetic flora provided by the invention can realize direct conversion of carbon dioxide into polyhydroxyalkanoate without additional carbon sources, has the advantage of environmental friendliness, and provides a new economical and feasible scheme and approach for production of polyhydroxyalkanoate.
Owner:MIBE (SHENZHEN) BIOTECHNOLOGY CO LTD

NMN efficient synthesis strain and construction method and production application thereof

The invention provides an NMN efficient synthesis strain and a construction method and production application thereof, and belongs to the technical field of engineering bacteria. According to the invention, firstly, an NMN synthesis route taking NAM as a substrate is constructed in escherichia coli, and specifically, NadV and PrsD128A are introduced into the escherichia coli, so that the NMN synthesis flux is improved; pnuC is introduced to promote the external arrangement of the NMN; the method comprises the following steps: knocking out PncC, NadR, UshA, NudC and MazG; pfkA and TalA are knocked out to improve the carbon flux of the pentose phosphate pathway. GDH1 and GDH2 are heterologously expressed in engineering bacteria to establish a reducing power balance system, the reducing power balance system is used for converting NADPH excessively accumulated in an NMN synthesis route into NADH, and meanwhile, an esaR-esaI group response element is introduced to dynamically regulate and control the system. The engineering strain constructed by the method can accumulate 3.0 g / L of NMN after 24-hour shake flask fermentation.
Owner:TIANJIN UNIV

Grape seed development gene VvPHERES1 and application thereof

The invention discloses a grape seed development gene VvPHERES1 and an application of the grape seed development gene VvPHERES1. The nucleotide sequence of the developmental gene VvPHERES1 is as shown in SEQ ID NO: 1. The amino acid sequence of the TypeI MADS transcription factor is as shown in SEQ ID NO: 2. According to the invention, the grape seed development related gene VvPHERES1 is cloned for the first time, and the gene function of the grape seed development related gene VvPHERES1 is researched. The method comprises the following steps: constructing a pCAMBIA2300-VvPHERES1 overexpression vector, and carrying out heterologous transformation on a Micro-Tom tomato plant. By comparing the change of seed characters in the overexpressed transgenic tomato and the wild type plant, the result shows that the number of seeds in the overexpressed transgenic tomato is obviously increased. The invention provides a gene related to regulation and control of grape seed development, and a basis is provided for seed selection of new seedless grape varieties.
Owner:XIAN BOTANICAL GARDEN SHAANXI PROV

Application of cultivated soybean SDR family gene GmGAE47

PendingCN119120526Areduce plant heightPlant height changesIsomerasesFermentationBiotechnologyHeterologous
The invention discloses an application of a soybean SDR family gene GmGAE47 in cultivation. The invention discloses a cultivated soybean GmGAE47 protein coding gene GmGAE47. The nucleotide sequence of the cultivated soybean GmGAE47 protein coding gene is SEQ ID NO. 1. The constructed plant overexpression vector Pba002-GmGAE47 is subjected to heterologous expression in a wild type of arabidopsis thaliana, and it is found that a transgenic plant changes in the aspects of plant height, thousand seed weight and grain width characters. The gene can be introduced into a plant as a target gene, and the plant height and yield of the transgenic plant are regulated and controlled through the expression of the GmGAE47 gene. Therefore, the cultivated soybean GmGAE47 protein coding gene GmGAE47 disclosed by the invention can be applied to the aspects of regulating the plant height, increasing the thousand seed weight, the grain width and the like through genetic engineering.
Owner:NANJING AGRICULTURAL UNIVERSITY

Recombinant pichia pastoris for expressing plastic degrading enzyme LCCICCG as well as construction method and application of recombinant pichia pastoris

The invention relates to the technical field of microorganisms, in particular to recombinant pichia pastoris for expressing plastic degrading enzyme LCCICCG as well as a construction method and application of the recombinant pichia pastoris. According to the invention, pichia pastoris is taken as a host cell, the coding gene lccICCG of the plastic degrading enzyme is heterologously expressed, and single-copy or multi-copy recombinant pichia pastoris is constructed. By optimizing culture conditions, the expression quantity and biomass of the plastic degrading enzyme protein are remarkably improved; by optimizing a fermentation strategy, high-density fermentation production of the LCCICCG protein in a 5L fermentation tank is realized, and a technical basis is provided for realizing large-scale industrial production of the protein. The improvements not only improve the production efficiency and reduce the cost of industrial production, but also provide powerful support for commercial application of the plastic depolymerases.
Owner:NANJING TECH UNIV

Uracil production strain as well as construction method and application thereof

The invention relates to the technical production field of metabolic engineering and genetic engineering, and particularly provides a uracil production strain as well as a construction method and application thereof. According to the strain, a uridine kinase gene udk is knocked out on an E.coli W3110 genome, and meanwhile, a T7RNA polymerase gene is integrated; the uridine monophosphate kinase gene pyrH is weakened; the method comprises the following steps: overexpressing a carbamyl phosphate synthetase gene carAB, a ribose phosphate pyrophosphate kinase gene prsA, a pyrimidine-5 '-nucleoside enzyme gene ppnN, UMP phosphohydrolase genes umpH and umpG, a ribonucleoside hydrolase 1 gene rihA and a glutamine synthetase gene glnA; an orotic acid nucleoside monophosphate decarboxylase gene pyrF and an orotic acid ribosyltransferase gene pyrE of wild type bacillus subtilis B.subtilis 168 are introduced in a heterologous manner, so that an orotate nucleoside monophosphate decarboxylase gene pyrF and an orotate ribosyltransferase gene pyrE are obtained. The safe, efficient and low-cost production of the uracil is realized.
Owner:新疆瑞诺生物科技有限公司

Chimeric promoter and use thereof

The invention relates to a chimeric promoter and application thereof. Nucleotide sequences of the chimeric promoter comprise: (1) a nucleotide sequence having at least 95% sequence identity with a nucleotide sequence shown in SEQ ID NO: 1; and (2) a nucleotide sequence as shown in SEQ ID NO: 1. The chimeric promoter provided by the invention has high activity, and can significantly increase the expression level of a target heterologous nucleotide sequence in plants.
Owner:BEIJING CERESTA BIOSCIENCECO LTD

The invention relates to 3apos; -adenosine monophosphate-5apos; phosphoryl sulfate synthetase mutant and application thereof

The invention discloses a 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant and an application of the 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant. Compared with a wild enzyme amino acid sequence as shown in SEQ ID NO.1, the amino acid sequence of the 3 '-adenosine-5'-phosphoryl sulfate synthetase mutant has one or two mutations in the 101 site, the 207 site and the 560 site; preferably, phenylalanine at the 101 site is mutated into tryptophan; cysteine at the 207th site is mutated into glycine; phenylalanine at the 560th site is mutated into tryptophan. The invention also provides a synthesis method and application of the 3 '-adenosine-5'-phosphoryl sulfuric acid. The APS intermediate product inhibition effect of hPAPSS1 is relieved through a point mutation technology, the substrate affinity of hPAPSS1 to ATP is improved, and a mutant enzyme with a high PAPS conversion rate is obtained; and the bifunctional enzyme hPAPSS1 is synthesized by heterologous expression of PAPS in escherichia coli, so that the acquisition of the enzyme is simplified, and the synthesis efficiency of PAPS is improved.
Owner:ZHEJIANG FORESTRY UNIVERSITY

L-valine production strain as well as construction method and application thereof

PendingCN120738083ABacteriaMicroorganism based processesHeterologousValine metabolism
The invention relates to an L-valine production strain as well as a construction method and application thereof, the strain is obtained by transformation through a metabolic synthesis path of L-valine, and the construction method comprises the following steps: by taking Cornebacterium glutamicum ATCC 13032 (C.glutamicum) as an original strain, carrying out editing transformation such as gene knockout, gene overexpression, gene heterologous expression, gene double-copy expression and the like on a genome of the original strain by utilizing a metabolic engineering means. The L-valine production strain disclosed by the invention can be used for synthesizing L-valine from the beginning by taking glucose as a carbon source, has the advantages of high production rate, short fermentation period, high strain stability and low cost, and lays a foundation for realizing large-scale production of L-valine. According to the fermentation tank fermentation method, the L-valine is produced in a mechanical stirring type fermentation tank by using the L-valine production strain Va1-09, 86.4 g / L of L-valine is produced by fermenting for 36 hours, and the method has a good industrial prospect.
Owner:JIANGSU YUANYIBANG BIOTECHNOLOGY CO LTD